ThinkRadial: A Prospective Study of Transradial deTACE in HCC Patients

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

August 21, 2018

Primary Completion Date

February 3, 2023

Study Completion Date

August 4, 2025

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

Transradial drug-eluting beadsTransarterial Chemoembolization (DEB-TACE)

Transarterial chemoembolization performed through the radial artery using HepaSphere drug-eluting microspheres in patients with hepatocellular carcinoma.

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT07160374 - ThinkRadial: A Prospective Study of Transradial deTACE in HCC Patients | Biotech Hunter | Biotech Hunter